HC Wainwright Has Positive Forecast for ACRS Q3 Earnings
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Investment analysts at HC Wainwright increased their Q3 2025 earnings per share estimates for Aclaris Therapeutics in a research note issued on Wednesday, May 14th. HC Wainwright analyst R. Selvaraju now anticipates that the biotechnology company will post earnings per share of ($0.14) for the quarter, up […]
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Investment analysts at HC Wainwright increased their Q3 2025 earnings per share estimates for Aclaris Therapeutics in a research note issued on Wednesday, May 14th. HC Wainwright analyst R. Selvaraju now anticipates that the biotechnology company will post earnings per share of ($0.14) for the quarter, up […]
